OLMA

NASDAQ · Biotechnology

Olema Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$14.90

-0.23 (-1.52%)

As of May 10, 10:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +12.8% upside

Low Target $15.48

Average Target $16.81

High Target $21.94

Current Price $14.90

Current
$14.90

Target
$16.81

$15.48 $16.81 avg $21.94

Scenario Analysis

Bear Case

$15.48

3.9%

Low target

Base Case

$16.81

+12.8%

Avg target

Bull Case

$21.94

+47.2%

High target

Risk/Reward

12.1x

Highly favorable

Price in Context

52-Week High

$36.26

-58.9% from high

52-Week Low

$3.89

+283.0% from low

Target vs 52W High

$16.81

-53.6% vs high

Next Earnings Report

May 12, 2026

Today

EPS Est: $-0.54

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%